TwoStep Therapeutics Secures US$62.5 Million Series A Financing and IND Clearance for TS-104

DLA Piper has advised TwoStep Therapeutics, Inc. TwoStep Therapeutics, Inc., a biotechnology company specializing in the development of multi-specific targeted therapies for solid tumors, has completed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here